DURECT Corp. (DRRX)
Current
- (-)
After Hours
Rating Performance
Rating Return
+37.34% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+37.34% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+37.34% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+453.47% vs
Rating Accuracy
100.0% (2 of 2*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-66.5%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-7.46%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-7.46%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+35.45%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
James E. Brown
Employees
90
Industry
Immunology Biopharmaceuticals
Sector
Healthcare
Headquarters
Cupertino
Exchange
NASDAQ
Website
http://www.durect.comSummary Stats
Market Cap
1.46B
Revenue
23.3M
Net Income
-31.9M
EPS
-$0.14
Price-to-Earnings
-45.86
Price-to-Book
41.97
Debt-to-Equity
0.97
News
Analyst Ratings
Price targets projected by 6 analysts
High
$7.00
Average
$6.17
Low
$5.00
Ratings calculated by 6 analysts
Buy
6
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q3 2022
Missed by $0.00
-$0.10 +-0.0%
-0.1
-0.04
Down 150%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--